A service of Salisbury University and University of Maryland Eastern Shore

Why Potentially Dodgy Diabetes Drugs Dominate in India

By Jason Beaubien
Published March 9, 2018 at 10:00 AM EST
  • Facebook
  • Twitter
  • Email
  • Facebook
  • Twitter
  • Email
Jason Beaubien
Jason Beaubien is NPR's Global Health and Development Correspondent on the Science Desk.
See stories by Jason Beaubien